Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia

Biology of Blood and Marrow Transplantation

Volumn 4, Issue 3, 1998, Pages 151-156

  Benjamin, Richard J ^a,b   Connors, Jean M ^a   McGurk, Siobhan ^a   Churchill, W Hallowell ^a   Antin, Joseph H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

BMT; CML; Plasmapheresis

Indexed keywords

ADULT; ALLOTRANSPLANTATION; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP TYPING; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PURE RED CELL ANEMIA; RETROSPECTIVE STUDY;

ABO BLOOD-GROUP SYSTEM; ADULT; BLOOD GROUPING AND CROSSMATCHING; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; RED-CELL APLASIA, PURE; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032254642     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.1998.v4.pm9923413     Document Type: Article

References (33)

1. Buckner CD, Clift RA, Sanders JE, Williams B, Gray M, Storb R, Thomas ED: ABO-incompatible marrow transplants. Transplantation 26:233, 1978.
2. Bensinger WI, Buckner CD, Thomas ED, Clift RS: ABO-incompatible marrow transplants. Transplantation 33:427, 1982.
3. Gale RP, Feig S, Ho W, Falk P, Rippee C, Sparkes R: ABO blood group system and bone marrow transplantation. Blood 50:185, 1977.
4. Lasky LC, Warkentin PI, Kersey JH, Ramsay NKC, McGlave PB, McCullough J: Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation. Transfusion 23:277, 1983.
5. Gmur JP, Burger J, Schaffner A, Neftel K, Oelz O, Frey D, Metaxas M: Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 75:290,1990.
6. Sniecinski I, Ritchey HB, Branch DR, Blume KG: Erythrocyte depletion of ABO-incompatible bone marrow. J Clin Apheresis 2:231, 1985.
7. Blacklock HA, Prentice HG, Evans JPM, Knight CBT, Gilmore MJML, Hazlehurst GRP, Ma DDF, Hoffbrand AV: ABO incompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion. Lancet 2:1061, 1982.
8. Sniecinski I, Oien L, Petz LD, Blume KG: Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 45:530, 1988.
9. Fujisawa S, Maruta A, Sakai R, Taguchi J, Tomita N, Oawa K, Kodama F, Takahashi K, Shibayama S, Kobayashi S, Ikuta K, Okubo T: Pure red cell aplasia after major ABO-incompatible bone marrow transplantation: two case reports of treatment with human erythropoietin. Transplant Int 9:506, 1996.
10. Heyll A, Aul C, Runde V, Arning M, Schnieder W, Wernet P: Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin. Blood 77:906, 1991.
11. Paltiel O, Cournoyer D, Rybka W: Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin. Transfusion 33:418, 1993.
12. Santamaria A, Sureda A, Martino R, Domingo-Albos A, Muniz-Diaz E, Brunet S: Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin. Bone Marrow Transplant 20:1105, 1997.
13. Ohta S, Yokoyama H, Ise T, Takasawa K, Wada T, Nakao S, Matsuda T, Kobayashi K: Apheresis therapy for prolonged red cell aplasia after major-mismatched bone marrow transplantation. Intern Med 36:487, 1997.
14. Roychowdhury DF, Linker CA: Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin. Bone Marrow Transplant 16:471, 1995.
15. Ohashi K, Akiyama H, Takamato S, Tanikawa S, Sakamaki H, Onozawa Y: Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplant 13:335, 1994.
16. Bierman PJ, Warkentin P, Hutchins MR, Klassen LW: Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin. Leuk Lymph 9:169, 1993.
17. Labar B, Bogdanic V, Nemet D, Kovacevic-Metelko J, Mrsic M, Pavletic Z, Zupancic-Salek S, Radman I, Aurer I: Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant. Bone Marrow Transplant 10:471, 1992.
18. Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH: ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion. In press.
19. Preti RA, Ahmed T, Ciavarella D: Comparison of the Cobe 2991 cell washer and the Haemonetics V50 apheresis system for automated bone marrow processing. Proc Annu Meet Am Assoc Cancer Res 32:A1016, 1991.
20. Antin JH, Bierer BE, Smith BR, Ferrara J, Guinan EC, Sieff C, Golan DE, Macklis RM, Tarbell NJ, Lynch E, Reichert TA, Blythman H, Bouloux C, Rappeport JM, Burakoff SJ, Weinstein HJ: Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematological malignancies. Blood 78:2139, 1991.
21. Antin JH, Weinstein HJ, Guinan EC, McCarthy P, Bierer BE, Gilliland G, Parsons SK, Ballen KK, Rimm IJ, Falzarano G, Bloedow DC, Abate L, Lebsack M, Burakoff SJ, Ferrara LM: Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease. Blood 84:1342, 1994.
22. Chao NJ, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD, Nademanee AP, Negrin RS, O'Donnell MR, Parker PM, Smith EP, Snyder DS, Stein AS, Wong RM, Blume KG, Forman SJ: Cyclosporine, methotrexate and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Engl J Med 329:1225, 1993.
23. Vengelen-Tyler V: Technical Manual. 12th ed. American Association of Blood Banks, Bethesda, MD, 640, 1996.
24. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1957.
25. Cockerill KJ, Lyding J, Zander AR: Red cell aplasia due to host type isoagglutinins with exuberant red cell progenitor production of donor type in an ABO-mismatched allogeneic bone marrow transplant recipient. Eur J Haematol 43:195, 1989.
26. Volin L, Ruutu T: Pure red-cell aplasia of long duration after major ABO-incompatible bone marrow transplantation. Acta Haematol 84:195, 1990.
27. Sahovic EA, Flick J, Graham CD, Stuart RK: Case report: isoimmune inhibition of erythropoiesis following ABO-incompatible bone marrow transplantation. Am J Med Sci 302:369, 1991.
28. Or R, Naparstek E, Mani N, Slavin S: Treatment of pure red cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation. Transplant Int 4:99, 1991.
29. Marmont AM, Frassoni F, van Lint MT, Bacigalupo A, Risso M: Isohemagglutinin induced pure red cell aplasia following major ABO incompatible marrow transplant for severe aplastic anemia. Resolution after plasma exchange. Exp Hematol 11 (Suppl 13):51, 1983.
30. Tichelli A, Gratwohl A, Wenger R, Osterwalder B, Nissen C, Burri HP, Speck B: ABO-incompatible bone marrow transplantation: in vivo adsorption, an old forgotten method. Transplant Proc 19:4632, 1987.
31. Porter DL, Roth MS, McGarigle C, Ferrara JL, Antin JH: Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 330:100, 1994.
32. Aubert EF, Boorman KE, Dodd BE: The agglutinin-inhibiting substance in human serum. J Path Bact 54:89, 1943.
33. Webb IJ, Soiffer RJ, Andersen JW, Cohen CA, Freeman A, Sugrue M, Ritz J, Anderson KC: In vivo adsorption of isoagglutinins prior to major ABO incompatible bone marrow transplantation. Biol Blood Marrow Transplant 3:267, 1997.